Spots Global Cancer Trial Database for metastatic adenocarcinoma of the pancreas
Every month we try and update this database with for metastatic adenocarcinoma of the pancreas cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Safety & Efficacy Study of Gemcitabine...With High Dose IV Vit. C (HDIVC) | NCT01654861 | Metastatic Aden... | Gemcitabine, In... | 18 Years - | Eastern Regional Medical Center | |
| Durvalumab and "Booster" Radiation in Metastatic Adenocarcinoma of the Pancreas | NCT03490760 | Adenocarcinoma ... | Durvalumab Radiation Thera... | 18 Years - | Baptist Health South Florida | |
| Study of Weekly Genexol®-PM Plus Gemcitabine in Subjects With Recurrent and Metastatic Adenocarcinoma of the Pancreas | NCT02739633 | Recurrent Adeno... Metastatic Aden... | Genexol-PM Gemcitabine | 20 Years - | Samyang Biopharmaceuticals Corporation | |
| Trial to Evaluate the Efficacy and Safety of Tarceva and Capecitabine in Advanced Pancreatic Cancer Patients | NCT00873353 | Metastatic Aden... | capecitabine + ... | 18 Years - | Grupo Gallego de Investigaciones Oncologicas | |
| Study of Weekly Genexol®-PM Plus Gemcitabine in Subjects With Recurrent and Metastatic Adenocarcinoma of the Pancreas | NCT02739633 | Recurrent Adeno... Metastatic Aden... | Genexol-PM Gemcitabine | 20 Years - | Samyang Biopharmaceuticals Corporation | |
| Trial to Evaluate the Efficacy and Safety of Tarceva and Capecitabine in Advanced Pancreatic Cancer Patients | NCT00873353 | Metastatic Aden... | capecitabine + ... | 18 Years - | Grupo Gallego de Investigaciones Oncologicas | |
| A Study to Assess the Effectiveness and Safety of Irinotecan Liposome Injection, 5-fluorouracil/Leucovorin Plus Oxaliplatin in Patients Not Previously Treated for Metastatic Pancreatic Cancer, Compared to Nab-paclitaxel+Gemcitabine Treatment | NCT04083235 | Metastatic Aden... | Irinotecan Lipo... Oxaliplatin 5Fluorouracil Leucovorin Nab-paclitaxel Gemcitabine | 18 Years - | Ipsen | |
| Phase 2 Study of Irinotecan Liposome Injection, Oxaliplatin, 5-fluorouracil/Levoleucovorin in Japanese Participants Not Previously Treated for Metastatic Adenocarcinoma of the Pancreas | NCT06225999 | Metastatic Aden... | Irinotecan lipo... Oxaliplatin LLV (levoisomer... 5- FU (5-Fluoro... | 18 Years - | Servier | |
| Minnelide Along With Abraxane Plus Gemcitabine in Patients With Metastatic Adenocarcinoma of the Pancreas | NCT05557851 | Metastatic Aden... | Minnelide | 19 Years - | Minneamrita Therapeutics LLC | |
| A Study to Assess the Effectiveness and Safety of Irinotecan Liposome Injection, 5-fluorouracil/Leucovorin Plus Oxaliplatin in Patients Not Previously Treated for Metastatic Pancreatic Cancer, Compared to Nab-paclitaxel+Gemcitabine Treatment | NCT04083235 | Metastatic Aden... | Irinotecan Lipo... Oxaliplatin 5Fluorouracil Leucovorin Nab-paclitaxel Gemcitabine | 18 Years - | Ipsen |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
